ArticleJournal of cardiothoracic surgery2026
Early recurrence of left atrial myxofibrosarcoma: A case report of a clinical and histopathologic challenge.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary cardiac tumors are rare, with an incidence of less than 0.33%, and the majority are benign. Sarcomas account for approximately 75% of malignant cardiac tumors, while myxofibrosarcomas represent less than 5% of these cases, making them extremely uncommon. This case report was prepared following the CARE guidelines to ensure comprehensive and transparent reporting and aims to describe the diagnostic and therapeutic challenges of cardiac myxofibrosarcoma. CASE PRESENTATION: A 60-year-old woman with no relevant medical history complained of epigastric pain, dyspnea, and diaphoresis, leading to a diagnosis of non-ST-elevation myocardial infarction. Transthoracic echocardiography revealed a heterogeneous 3.2 × 3.0 cm mass attached to the atrial side of the anterior mitral valve leaflet, which was subsequently surgically removed. Histological examination of the resected mass identified abundant fibrin, vascular proliferation, and sparse cellularity without definitive evidence of malignancy, suggesting an organized intracardiac thrombus as a differential diagnosis. Four months later, the patient developed progressive dyspnea, orthopnea, and fatigue. Further evaluation with cardiac magnetic resonance imaging revealed a recurrent 4.4 × 4.0 cm mass in the left atrium, obstructing mitral inflow. A second surgical resection and valve replacement were performed. The histopathological analysis identified polygonal and spindle-shaped myofibroblasts embedded in a myxoid stroma with scattered lymphocytes, plasma cells, and focal necrosis. Immunohistochemical staining showed focal positivity for Smooth Muscle Actin, CD34, and p53, with negative staining for h-caldesmon, myogenin, CKAE1/3, CD117, S100, calretinin, MDM2, calponin, D2-40, MyoD1, and CD31confirming the diagnosis of myxofibrosarcoma.
conclusionsCardiac myxofibrosarcomas are rare but aggressive tumors with a potential for recurrence. This case highlights the diagnostic challenges posed by their atypical presentation and the risk of initial misdiagnosis. Regular follow-up using multimodal imaging, particularly cardiac magnetic resonance, is crucial for early detection and timely intervention of recurrence. A multidisciplinary approach involving cardiologists, radiologists, pathologists, and cardiac surgeons is essential to optimize diagnosis, treatment, and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.